Predicting poor vaccine responders to Hepatitis B vaccination

Go Back to All Clinical Trials

Predicting poor vaccine responders to Hepatitis B vaccination

Brief description of study

The purpose of this study is to understand how the immune system learns from the hepatitis B vaccine and why some people do not respond to the vaccine. Approximately 5-50% (5-50 in 100) of people who need hepatitis B vaccine do not develop immunity despite getting three doses of the classic vaccine. The immune system “learns” from a vaccine through the actions and changes to T and B cells (types of cells in your immune system), but there are many details that we do not understand. Understanding how people respond to different versions of the hepatitis B vaccine will help researchers understand how to design better, more effective vaccines.

Clinical Study Identifier: s20-01782

ClinicalTrials.gov Identifier: NCT04674462

Principal Investigator: Ramin Herati.

Other Investigator: Mark J. Mulligan.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies